Showing results (1711-1720 of 2,418) with videos related to

Sort By:
Pageof 242
Quantitative Imaging in Medicine and Surgery|April 30, 2019
Partial splenic embolization with Glubran®2/Lipiodol® mixture for oncological patients with hypersplenism-related thrombocytopenia requiring systemic chemotherapyRomaric Loffroy, Nicolas Falvo, Motoki Nakaï, et al.
Nanoscale|May 18, 2017
Combining light-harvesting with detachability in high-efficiency thin-film silicon solar cellsSanjay K Ram, Derese Desta, Rita Rizzoli, et al.
Investigative Ophthalmology & Visual Science|December 24, 2010
Bacterial infection in scarring trachomaVictor H Hu, Patrick Massae, Helen A Weiss, et al.
British Journal of Cancer|August 1, 1996
A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of CancerV Dieras, B Chevallier, P Kerbrat, et al.
Journal of Viral Hepatitis|October 27, 2004
Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational databaseN Voirin, C Trépo, P Miailhes, et al.
Brachytherapy|July 30, 2017
High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemesAlexander T Falk, Sylvain Demontoy, Emmanuel Chamorey, et al.
Journal of Clinical Pathology|January 8, 2009
Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slidesD Wendum, K Lacombe, M Chevallier, et al.
Transplantation|November 5, 2016
Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood TransplantationPauline Rettman, Catherine Willem, Christelle Volteau, et al.
Bulletin Du Cancer|November 18, 2018
[Development of a standardized guide for optimizing drug adherence information to be dispensed during a pharmaceutical counseling with a multiple myeloma patient: Final validation]Camille Favier-Archinard, Géraldine Leguelinel-Blache, Christelle Cousin, et al.
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Pageof 242